CORT – Knox Daily

Insiders Updates

CORT’s latest rating updates from top analysts.

In a filing, Corcept Therapeutics Inc revealed its Director Swisher Daniel N JR unloaded Company’s shares for reported $0.13 million

Insiders Updates

Investing in Corcept Therapeutics Inc (CORT) Is Getting More Attractive

Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.32 million on

Analysts Viewpoint

Corcept Therapeutics Inc [CORT] Chief Development Officer makes an insider sale of 6,606 shares worth 323,496.

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Corcept Therapeutics

Stock Earnings

Taking a Closer Look At Corcept Therapeutics Inc (CORT) Following Its Recent Trade

Corcept Therapeutics Inc’s filing revealed that its Officer Guyer William acquired Company’s shares for reported $0.49 million on Nov 01

Insiders Updates

Corcept Therapeutics Inc [CORT] Chief Development Officer makes an insider purchase of 10,000 shares worth 0.46 million.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Corcept Therapeutics Inc [CORT] Guyer William sells 10,000 Shares for $0.46 million

Corcept Therapeutics Inc’s recent filing unveils that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million

Analysts Viewpoint

CORT Stock Sees Surge of Approximately 0.15% in Last Five Days

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Corcept Therapeutics Inc [CORT] Insider Guyer William sells 10,000 Shares for $10,000

Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million on

Insiders Updates

Corcept Therapeutics Inc [NASDAQ: CORT] Sees Decrease in Stock Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Truist upgrades Corcept Therapeutics Inc (CORT) rating to a Buy

Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $0.46 million on

Tag: CORT